Cargando…

Correction: Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma

Detalles Bibliográficos
Autores principales:	Jiang, Lei, Xu, Yulian, Zeng, Xinli, Fang, Jianchen, Morse III, Herbert C., Zhou, Jeff X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458292/ https://www.ncbi.nlm.nih.gov/pubmed/28499331 http://dx.doi.org/10.18632/oncotarget.17684

Ejemplares similares

Suppression of CD300A inhibits the growth of diffuse large B-cell lymphoma
por: Jiang, Lei, et al.
Publicado: (2015)

Loss of IRF8 Inhibits the Growth of Diffuse Large B-cell Lymphoma
por: Xu, Yulian, et al.
Publicado: (2015)

Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma
por: Ogasawara, Ken, et al.
Publicado: (2021)

Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study
por: Paunescu, Alexandra‑Cristina, et al.
Publicado: (2021)

Correction: Ectopic Expression of Homeobox Gene NKX2-1 in Diffuse Large B-Cell Lymphoma Is Mediated by Aberrant Chromatin Modifications
por: Nagel, Stefan, et al.
Publicado: (2013)

Correction to Lancet Microbe 2020; 1: e300–07
Publicado: (2020)

Correction: MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Publicado: (2014)

Correction: MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
por: Yan, Li-Xu, et al.
Publicado: (2018)

Correction: Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway
por: Peng, Yulin, et al.
Publicado: (2023)

Correction for: Curcumin in combination with homoharringtonine suppresses lymphoma cell growth by inhibiting the TGF-β/Smad3 signaling pathway
por: Zhang, Yu, et al.
Publicado: (2022)

Correction: Roscovitine Suppresses CD4+ T Cells and T Cell-Mediated Experimental Uveitis
por: Zhang, Zili, et al.
Publicado: (2013)

Plasma Factors for the Differentiation of Hodgkin’s Lymphoma and Diffused Large B Cell Lymphoma and for Monitoring Remission
por: Zeng, Qun, et al.
Publicado: (2019)

Correction to: Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy
por: Wang, Chunmeng, et al.
Publicado: (2021)

Author Correction: Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL
por: Bhalla, Kavita, et al.
Publicado: (2018)

Publisher Correction: The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP
por: Wei, Xiaolei, et al.
Publicado: (2019)

Correction to: Approximation of Long-Term Survival with Polatuzumab Vedotin Plus Bendamustine and Rituximab for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results Based on The GO29365 Trial
por: Felizzi, F., et al.
Publicado: (2022)

Correction: Promoter-Bound p300 Complexes Facilitate Post-Mitotic Transmission of Transcriptional Memory
Publicado: (2014)

Leukemic Phase of CD5+ Diffuse Large B-Cell Lymphoma
por: Hsiao, Hui-Hua, et al.
Publicado: (2018)

CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma
por: Gambella, Massimiliano, et al.
Publicado: (2022)

Correction: Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function
por: Dyck, Lydia, et al.
Publicado: (2022)

Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma
por: Prutsch, Nicole, et al.
Publicado: (2020)

Inhibition of MALT1 protease activity is selectively toxic for activated B cell–like diffuse large B cell lymphoma cells
por: Ferch, Uta, et al.
Publicado: (2009)

Somatic Mitochondrial DNA Mutations in Diffuse Large B-Cell Lymphoma
por: Zeng, Andy G. X., et al.
Publicado: (2018)

Diffuse Large B-Cell Lymphoma Promotes Endothelial-to-Mesenchymal Transition via WNT10A/Beta-Catenin/Snail Signaling
por: Sun, Xianting, et al.
Publicado: (2022)

Correction: Sumoylation Inhibits the Growth Suppressive Properties of Ikaros
Publicado: (2016)

Correction: Bocci et al. Remarkable Remission Rate and Long-Term Efficacy of Upfront Metronomic Chemotherapy in Elderly and Frail Patients, with Diffuse Large B-Cell Lymphoma. J. Clin. Med. 2022, 11, 7162
por: Bocci, Guido, et al.
Publicado: (2023)

Primary CD20‐positive mediastinal diffuse large B‐cell lymphoma
por: Rajabto, Wulyo, et al.
Publicado: (2020)

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
por: Zhang, Wenqi, et al.
Publicado: (2021)

Correction: CD137 Facilitates the Resolution of Acute DSS-Induced Colonic Inflammation in Mice
por: Martínez Gómez, Julia M., et al.
Publicado: (2014)

Correction: Ago HITS-CLIP Expands Understanding of Kaposi's Sarcoma-associated Herpesvirus miRNA Function in Primary Effusion Lymphomas
por: Haecker, Irina, et al.
Publicado: (2013)

The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma
por: Yang, Jing, et al.
Publicado: (2019)

Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Harris, Leonard Jeff, et al.
Publicado: (2020)

Correction: A Human Trypanosome Suppresses CD8(+) T Cell Priming by Dendritic Cells through the Induction of Immune Regulatory CD4(+) Foxp3(+) T Cells
por: Ersching, Jonatan, et al.
Publicado: (2016)

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
por: Ma, Xiao‐bo, et al.
Publicado: (2018)

Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma
por: Nie, Man, et al.
Publicado: (2021)

Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma
por: Araf, Shamzah, et al.
Publicado: (2019)

Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth
por: Haery, Leila, et al.
Publicado: (2014)

Anti-CD20–atezolizumab–polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphoma
por: Topp, Max S., et al.
Publicado: (2022)

CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma
por: Quintás-Cardama, Alfonso
Publicado: (2018)

CD7-Positive Diffuse Large B-Cell Lymphoma Presenting as an Intranasal Tumor
por: Teshima, Kazuaki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1r98r9fe7cbvfd4k59v6hthflt